Reviewer leaks confidential NEJM study to GSK FDA rejects Labopharm’s Tramadol after response to second approvable letter KV acquires Gestiva from Hologic in $82 million deal FDA approves Mylan’s generic Kytril Ten-year Medicare costs $117 billion lower than original estimates FDA warns of increased thoughts of suicide associated with antiepileptic drugs Novo Nordisk's Changing Diabetes World Tour Coverage from the Novo Nordisk Changing Diabetes World Tour, New York City, Nov. 13, 2007 First Previous 633 634 635
